Guillem Garcia-Llorens - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Journal of Personalized Medicine|July 27, 2022

Modeling a Novel Variant of Glycogenosis IXa Using a Clonal Inducible Reprogramming System to Generate "Diseased" Hepatocytes for Accurate DiagnosisGuillem Garcia-Llorens, Sergi Lopez-Navarro, Teresa Jaijo, et al.

Stem Cell Research & Therapy|April 19, 2023

A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studiesGuillem Garcia-Llorens, Teresa Martínez-Sena, Eugenia Pareja, et al.

International Journal of Molecular Sciences|May 25, 2024

Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome PathwaysErnesto López-Pascual, Ivan Rienda, Judith Perez-Rojas, et al.

Scientific Reports|February 11, 2022

Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selectionRamon Santamaria, Maria Ballester, Guillem Garcia-Llorens, et al.

Biofabrication|April 15, 2026

Organobodies: A robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screeningMostafa Kiamehr, Stefano Manzini, Burak Toprakhisar, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Journal of Personalized Medicine|July 27, 2022

Modeling a Novel Variant of Glycogenosis IXa Using a Clonal Inducible Reprogramming System to Generate "Diseased" Hepatocytes for Accurate DiagnosisGuillem Garcia-Llorens, Sergi Lopez-Navarro, Teresa Jaijo, et al.

Stem Cell Research & Therapy|April 19, 2023

A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studiesGuillem Garcia-Llorens, Teresa Martínez-Sena, Eugenia Pareja, et al.

International Journal of Molecular Sciences|May 25, 2024

Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome PathwaysErnesto López-Pascual, Ivan Rienda, Judith Perez-Rojas, et al.

Scientific Reports|February 11, 2022

Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selectionRamon Santamaria, Maria Ballester, Guillem Garcia-Llorens, et al.

Biofabrication|April 15, 2026

Organobodies: A robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screeningMostafa Kiamehr, Stefano Manzini, Burak Toprakhisar, et al.

Pageof 1